BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23958573)

  • 1. Endostatin levels and the risk of subsequent preeclampsia.
    Thissier-Levy S; Boucoiran I; Luo ZC; Nuyt AM; Julien P; Fraser WD; Audibert F
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):396-400. PubMed ID: 23958573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
    Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
    Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated measures of placental growth factor, placental protein 13, and a disintegrin and metalloprotease 12 at first and second trimesters for preeclampsia screening.
    Boucoiran I; Suarthana E; Rey E; Delvin E; Fraser WB; Audibert F
    Am J Perinatol; 2013 Sep; 30(8):681-8. PubMed ID: 23386402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating levels of the antiangiogenic factor endostatin in early-onset but not late-onset preeclampsia.
    Wikström AK; Larsson A; Akerud H; Olovsson M
    Reprod Sci; 2009 Oct; 16(10):995-1000. PubMed ID: 19564642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
    Akolekar R; Syngelaki A; Beta J; Kocylowski R; Nicolaides KH
    Prenat Diagn; 2009 Dec; 29(12):1103-8. PubMed ID: 19777530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.
    Lai J; Pinas A; Syngelaki A; Poon LC; Nicolaides KH
    J Matern Fetal Neonatal Med; 2013 May; 26(8):733-7. PubMed ID: 23205865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
    Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
    Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a panel of maternal serum markers in predicting preeclampsia at 11-15 weeks' gestation.
    Banzola I; Farina A; Concu M; Sekizawa A; Purwosunu Y; Strada I; Arcelli D; Simonazzi G; Caramelli E; Rizzo N
    Prenat Diagn; 2007 Nov; 27(11):1005-10. PubMed ID: 17654753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on clinical risk of maternal underlying medical conditions and onset of preeclampsia].
    Shen J; Yang Z; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):405-11. PubMed ID: 22932104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.
    Mosimann B; Wagner M; Birdir C; Poon LC; Nicolaides KH
    J Matern Fetal Neonatal Med; 2013 May; 26(8):763-7. PubMed ID: 23205868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia.
    Sun F; Qian W; Zhang C; Fan JX; Huang HF
    Med Sci Monit; 2017 Nov; 23():5396-5401. PubMed ID: 29129906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.
    Gallo D; Poon LC; Fernandez M; Wright D; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(1):28-37. PubMed ID: 24752037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum vitamin D levels at 11-13 weeks of gestation in preeclampsia.
    Yu CK; Ertl R; Skyfta E; Akolekar R; Nicolaides KH
    J Hum Hypertens; 2013 Feb; 27(2):115-8. PubMed ID: 22336906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia.
    Mahmound RA; Abdel-Raouf M
    East Mediterr Health J; 2006; 12(1-2):178-87. PubMed ID: 17037236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is afamin a potential early biomarker for subsequent development of preeclampsia? A nested case-control study.
    Çalışkan CS; Celik S; Avcı B
    J Matern Fetal Neonatal Med; 2021 Jun; 34(12):2006-2011. PubMed ID: 33028116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum anti-Müllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia.
    Birdir C; Fryze J; Vasiliadis H; Nicolaides KH; Poon LC
    J Matern Fetal Neonatal Med; 2015 May; 28(8):865-8. PubMed ID: 24953352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester.
    Kim SY; Park SY; Kim MJ; Lee BY; Han JY; Ryu HM
    J Matern Fetal Neonatal Med; 2013 Jun; 26(9):860-5. PubMed ID: 23343007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.
    Enquobahrie DA; Williams MA; Butler CL; Frederick IO; Miller RS; Luthy DA
    Am J Hypertens; 2004 Jul; 17(7):574-81. PubMed ID: 15233976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of immunoglobulin E and the subsequent risk of pre-eclampsia: a population-based study.
    Eskild A; Nilsen TI; Jeansson S; Jenum PA; Vatten LJ
    Acta Obstet Gynecol Scand; 2008; 87(3):373-6. PubMed ID: 18307080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester metabolomic detection of late-onset preeclampsia.
    Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
    Am J Obstet Gynecol; 2013 Jan; 208(1):58.e1-7. PubMed ID: 23159745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.